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Abstract
Background: A variety of pathways target CDKI p21WAF1/CIP1 expression at transcriptional, post-transcriptional as
well as translational levels. We previously found that cell growth suppressing retinoid CD437 enhanced expression
of p21WAF1/CIP1 and DNA damage inducible GADD45 proteins in part by elevating their mRNA stability.
Results: Here, we investigated molecular mechanisms of CD437-dependent post-transcriptional regulation of
p21WAF1/CIP1 expression. By utilizing MDA-MB-468 HBC cells expressing chimeric rabbit b-globin-p21WAF1/CIP1
transcripts we mapped multiple CD437-responsive sequences located within positions 1195 to 1795 of the
3′-untranslated region of p21WAF1/CIP1 mRNA. Several cytoplasmic proteins present in MDA-MB-468, MCF-7 HBC as
well as HL-60R leukemia cells bound specifically, in vitro, with these CD437-responsive sequences. CD437 treatment
of cells resulted in elevated binding of ~85 kD and ~55 kD cytoplasmic proteins with putative CD437-responsive
sequences. A 12 nt RNA sequence (5′-UGUGGUGGCACA-3′) present within CD437-responsive region of p21WAF1/CIP1
mRNA displayed specific and elevated binding with the above noted proteins. Treatment of cells with ActD or CHX
prior to CD437 exposure did not abrogate RNA-protein interactions. However, treatment of cytoplasmic protein
extracts with proteinase K or alkaline phosphatase resulted in loss of RNA-protein interactions.
Conclusions: CD437 regulates cell growth in part by regulating stability of p21WAF1/CIP1 mRNA that involves
specific RNA-protein interactions that are phosphorylation-dependent, while not requiring nascent transcription or
protein synthesis.

Background
CDKI p21WAF1/CIP1, an important cell-cycle regulatory
molecule, was originally identified as a gene regulated
by the tumor suppressor protein p53 [1]. Subsequent
studies also demonstrated induction of p21WAF1/CIP1 via
mechanisms independent of p53 [[2], refs within].
Indeed, exposure of cells to a wide variety of stress
agents leads to induction of p21 WAF1/CIP1 , which, in
turn, participates in mediating cell-cycle arrest. It is
thought that cell-cycle arrest due to induction of
p21WAF1/CIP1 following exposure of cells to stress stimuli, functions as a protective factor in determining the
survival of the cell. The mechanisms underlying stress* Correspondence: Rishia@Karmanos.org
5
Karmanos Cancer Institute, Department of Internal Medicine, Wayne State
University and John D. Dingell VA Medical Center, Room B4325, 4646 John
R, Detroit, MI 48201, USA
Full list of author information is available at the end of the article

induced expression of p21WAF1/CIP1 have been found to
involve both transcriptional as well as post-transcriptional processes [[2], refs within]. Numerous transcription factors, including p53, Sp1, p300, CEBPb, AP2, and
STATs, have previously been shown to regulate
p21WAF1/CIP1 transcription [[2], refs within]. In addition,
the transcription factor CEBPa has been found to
associate with the p21WAF1/CIP1 protein and as a result
considerably extended the p21WAF1/CIP1 protein half-life
[3]. Regulation of mRNA turnover has also been found
to be an important determinant in the stress-induced
expression of p21WAF1/CIP1 [4-7].
CD437 belongs to a class of adamantyl-substituted
retinoids that suppress growth by inducing cell-cycle
arrest as well as apoptosis in a number of cell types
including HBC, prostate carcinoma, leukemia and normal mammary epithelial cells [8-11]. CD437, designed
as an retinoic acid receptor (RAR)g-selective molecule,
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exerts its action through RAR/retinoid X nuclear receptor (RXR)-independent as well as p53-independent pathway. CD437 treatment induces expression of p21WAF1/
CIP1
mRNA and protein in a number of cell types
[8-11]. In this report we demonstrate that CD437dependent induction of p21 WAF1/CIP1 in HBC cells is
accomplished, in part, by targeting multiple, novel
sequences within an approximately 600 nt subfragment
of the 3′-UTR of p21 WAF1/CIP1 mRNA. Further, we
report identification of a 12 nt p21 WAF1/CIP1 mRNA
sequence that shows specific binding, in vitro, with multiple cytoplasmic protein complexes present in HBC and
HL-60R leukemia cells. CD437 causes elevated binding,
in vitro, of ~55 kD and 85 kD-sized cytoplasmic complexes with these sequences.

Results
The 3′-UTR of p21WAF1/CIP1 harbors destabilizing and
CD437-responsive cis element(s)

To determine whether sequences present in the p21WAF1/
3′-UTR cause instability of heterologous rabbit bglobin (RBG) mRNA, as well as harbor CD437-responsive
elements, we utilized MDA-MB-468 HBC sublines that
stably express RBG or RBG-WAF (581-2004) transcripts
in the following experiments. First, the cells were either
untreated or treated with 1 μM CD437 followed by analysis of expression of RBG or RBG-WAF transcripts by
northern blot hybridization as described in the methods.
CD437 treatment resulted in elevated levels of RBGWAF (581-2004) transcripts, while no such increase in
expression of RBG mRNA was noted (figure 1). Next,
multiple, independent sublines expressing RBG or RBGWAF (581-2004) transcripts were separately incubated in

CIP1

Figure 1 CD437 regulation of chimeric rabbit b-globinp21WAF1/CIP1 mRNA. Two independent sublines derived from
transfection of RGB-WAF (581-2004) plasmid [31.4(A4) and 31.4(C5)]
or RBG plasmid [29.6(1) and 29.6(2)] were grown either in the
absence (-) or presence (+) of 1 μM CD437 for 48 hours. Total RNAs
were prepared and expression of RBG transcripts analyzed by
northern blot hybridization as described [12]. Levels of RNA loading
in each lane were assessed by signals from hybridization with
ribosomal phosphoprotein 36B4 cDNA [18]
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the presence or absence of CD437 for 40 hours, followed
by their treatments with 4 μg/ml ActD for additional 2,
4, 6, 8, or 10 hours. Total cellular RNAs were isolated
and expression of RBG and RBG-WAF (581-2004) transcripts analyzed by northern blot as in Methods. As
shown in figure 2A, CD437 treatments enhanced expression of chimeric RBG-WAF (581-2004) transcripts. The
expression of RBG mRNA, on the other hand, was unaltered following similar treatments with ActD in the
absence or presence of CD437 (data not shown). Next,
the northern blot data from two and four independent
sublines expressing RBG and RBG-WAF (581-2004)
mRNAs, respectively, that were treated with ActD in the
absence or presence of CD437 as in figure 2A, was utilized in calculating rate of decay of the RBG and RBGWAF (581-2004) transcripts. The half-life (t½) of RBG
and RBG-WAF (581-2004) transcripts was calculated as
described before [12]. The RBG-WAF (581-2004) transcripts displayed a half-life of ~4 h in comparison
to RBG transcripts that were found to be very stable
(figures 2B and 2C). Thus, the data in figure 2 suggest
that the 3′-UTR of p21WAF1/CIP1 contains sequences that
affect stability of the RBG transcripts in the HBC cells.
Further, CD437 treatment of HBC cells expressing RBGWAF (581-2004) transcripts resulted in significant
enhancement (~4-fold) of the stability of the chimeric
transcripts (figure 2B). Together, data in figures 1 and 2
demonstrate that the ~1.4 kb long 3′-UTR of p21WAF1/
CIP1
mRNA contains elements that regulate stability of
RBG mRNAs in HBC cells dependent as well as independent of CD437.
Multiple CD437-responsive sequences exist within
p21WAF1/CIP1 3′-UTR

To further map CD437-responsive sequences, independent sublines harboring plasmids expressing various chimeric RBG-WAF transcripts were utilized (table 1).
Each of the sublines was independently cultured in the
presence or absence of CD437 (1 μM) for 48 hours, followed by extraction of total RNA and northern blot
hybridization to determine expression of chimeric transcripts (not shown). As summarized in table 1, CD437
treatments resulted in elevated expression of RBG-WAF
transcripts in all the sublines except those expressing
RBG-WAF (1795-2004), RBG-WAF (1900-2004), RBGWAF (581-1195), and RBG-WAF (581-1011) transcripts
indicating the presence of CD437-responsive cis elements within positions 1195 to 1795 of p21WAF1/CIP1
mRNA [1]. As also noted in table 1, CD437 stimulated
expression of chimeric transcripts in HBC sublines harboring RBG-WAF (1645-2004), RBG-WAF (1498-1645),
and RBG-WAF (581-1498) constructs that have nonoverlapping fragments of p21WAF1/CIP1 3′-UTR. These
data support the possibility of multiple, independently
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functional CD437-responsive sequences within the
p21WAF1/CIP1 3′-UTR. Interestingly, CD437 treatment of
HBC sublines expressing the WAF (1540-1700)-RBG
transcript (table 1), in which the p21WAF1/CIP1 mRNA
sequences were positioned at the 5′ end of the RBG
transcript also resulted in elevated levels of chimeric
transcripts (figure 3). Since, the plasmids RBG-WAF
(1540-1700) and WAF (1540-1700)-RBG have sense
orientation of identical p21WAF1/CIP1 3′-UTR sequences
(from positions 1540-1700, [1]) positioned at the 3′ and
5′ ends, respectively, of the RBG gene, the elevated
expression of chimeric transcripts derived from these
constructs noted in figure 3 further underscore the fact
that CD437-responsive RNA sequences function independent of their location in the target mRNA. The data
in figure 3 thus corroborate our previous finding where
CD437-dependent expression of GADD45 involved
RNA sequences located at the 5′-UTR of GADD45
mRNA [12].
Multiple cytoplasmic proteins bind specifically to
CD437-responsive UTR subfragments of p21WAF1/CIP1 and
GADD45 mRNAs, and their binding is enhanced following
treatment of cells with CD437

Figure 2 Presence of p21WAF1/CIP1 3’-UTR causes destabilization
of RBG mRNA, while CD437 treatments enhance stability of
chimeric RBG-WAF transcripts. MDA-MB-468 sublines derived from
stable transfection of RBG-WAF (581-2004) plasmid (Panel A) or RBG
plasmid (not shown) were cultured in the absence (-) or presence
(+) of CD437 for 48 hours and exposed to transcriptional inhibitor
ACT D for noted times. The preparation of RNA and northern blot
hybridization were as described in the legend to figure 1. Panels B
and C show plots of the decay of RBG transcripts in either the
presence or absence of CD437. The RBG mRNA levels at time 0 in
either the absence or presence of CD437 were arbitrarily defined as
1. Data in panels B and C represent mean of four and two
independent sublines, respectively, for each time point. Error bars
represent the standard error of the mean.

The possibility of specific RNA-protein interactions
involved in CD437-dependent regulation of p21 WAF1/
CIP1
and GADD45 expression was investigated as follows. First, pBKS-WAF (581-2110), pBKS-WAF (15401700), and pBKS-GADD (10-55) plasmids (table 2) were
utilized to synthesize unlabelled as well as radiolabelled
RNAs as described in Methods. Next, the in vitro binding of the cellular cytoplasmic proteins derived from
untreated as well as CD437-treated HBC cells to the
above radiolabelled probes was investigated by UVinduced cross-linking. The 160 nt subfragment of
p21WAF1/CIP1 3′-UTR present in the plasmid pBKS-WAF
(1540-1700) binds specifically with multiple cytoplasmic
protein complexes, and pre-treatment of HBC cells with
CD437 results in elevated binding with three major
cytoplasmic protein complexes of ~85, 55, and 40 kD
sizes (figure 4; panel A, lanes 2, 3; panel B, lane 2). The
presence of 200-fold excess of this unlabelled probe
abolished the above RNA-protein interactions (figure 4;
panel A, lanes 4, 5, 6; panel B, lane 3), while these interactions were unaffected by the presence of 200-fold
excess of non-specific RNA (figure 4; panel A, lane 7).
Like the p21WAF1/CIP1 3′-UTR subfragment probe, the
GADD45 5′-UTR probe derived from pBKS-GADD (1055) plasmid (table 2) also showed specific binding with
multiple cytoplasmic complexes and pre-treatment of
HBC cells with CD437 caused elevated binding of the
above noted three major cytoplasmic protein complexes
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Table 1 CD437-responsive sequences of p21WAF1/CIP1 3’-UTR
Construct ID

Plasmid Name

Positions of p21WAF1/CIP1 3’-UTR insert [4]

CD437 Responsiveness

29.6

RBG

—————

—————

31.4

RBG-WAF (581-2004)

+581 to +2004

Yes

30.2

RBG-WAF (1006-2004)

+1006 to +2004

Yes

32.8

RBG-WAF (1498-2004)

+1498 to +2004

Yes

33.7

RBG-WAF (1645-2004)

+1645 to +2004

Yes

36.4

RBG-WAF (1795-2004)

+1795 to +2004

No

37.4

RBG-WAF (1900-2004)

+1900 to +2004

No

38.1

RBG-WAF (1498-1645)

+1498 to +1645

Yes

49.1

RBG-WAF (1540-1700)

+1540 to +1700

Yes

50.1

WAF (1540-1700)-RBG

+1540 to +1700

Yes

60.3

RBG-WAF (581-1498)

+581 to +1498

Yes

61.2

RBG-WAF (581-1195)

+581 to +1195

No

62.3

RBG-WAF (581-1011)

+581 to +1011

No

of ~85, 55, and 40 kD sizes (Figure 4B, lane 5). The
binding of these complexes was also abolished by a 200fold excess of unlabelled probe (figure 4B, lane 6), but
remained unaffected by the presence of 200-fold excess
of non-specific RNA (figure 4B, lane 7). Furthermore,
labeled probe synthesized from plasmid pBKS-WAF
(581-2110) also showed specific binding to several cytoplasmic protein complexes derived from untreated as
well as CD437-treated HBC cells (figure 4A). In addition
to the above noted ~85, 55 and 40 kD complexes, several other RNA-protein complexes were found in the
lane containing extracts from untreated HBC cells (lane
8, figure 4A). The elevated and specific binding of several RNA-protein complexes, including 85, 55, and 40
kD, as well as additional ~25 and 35 kD species was evident in the lanes having extracts derived from CD437treated HBC cells (figure 4A; lanes 9, 10). Together,
data in figure 4A and 4B, suggest that CD437 causes
enhanced expression of p21 WAF1/CIP1 and GADD45
mRNAs in HBC cells, in part, by targeting specific
RNA-protein interactions. These RNA-protein interactions involve elevated binding of putative 85, 55, and 40
kD proteins to the CD437-responsive target RNA
sequences.
Cytoplasmic proteins interacting with CD437-responsive
p21WAF1/CIP1 3′-UTR subfragment are also present in
different cell types

To further elucidate RNA cis-trans interactions involved
in post-transcriptional regulation of p21 WAF1/CIP1
expression, cytoplasmic extracts from untreated and
CD437-treated MDA-MB-468 and MCF-7 HBC cells as
well as HL-60R human leukemia cells were prepared as
described in Methods. Radio-labeled probe derived from
pBKS-WAF (1540-1700) plasmid (table 2) was utilized
to study in vitro binding of cytoplasmic proteins. Figure

4C shows that pretreatment of HBC as well as leukemia
cells with CD437 results in elevated binding of the
above noted ~85 kD, 55 kD and 40 kD cytoplasmic protein complexes (lanes 3-5, 8-11, and 14). The elevated
RNA-protein interactions were noted following 3-6
hours and 1 hour treatments of HBC (MCF-7 and
MDA-MB-468) and leukemia cells, respectively. The
data in figure 4C thus are consistent with earlier observations where 1 and 6 hours of CD437 treatments
caused induction of p21WAF1/CIP1 in HL-60R leukemia
and HBC cells, respectively [8,12]. Together, the data in
figure 4 underscore the conservation of RNA-protein
interactions involved in the regulation of p21WAF1/CIP1
and GADD45 expression in different cell types in the
presence of CD437.
RNA cis-trans interactions with the CD437-responsive
p21WAF1/CIP1 3′-UTR subfragment are phosphorylationdependent

To investigate the molecular basis of RNA-protein interactions targeted by CD437, the following experiments
were conducted. MDA-MB-468 HBC cells were pretreated with either transcriptional inhibitor ActD or protein synthesis inhibitor CHX for 1 hour, followed by
their culture in the absence or presence of 1 μM CD437
for an additional 6 hours. The cytoplasmic extracts were
prepared and RNA-protein interactions analyzed as
above. In addition, HBC cell cytoplasmic extracts that
were prepared after 24 hours of 1 μM CD437 treatment
were subjected to either alkaline phosphatase or Proteinase K as detailed in Methods prior to their utilization
in binding reactions in vitro. figure 5, lanes 2 and 4,
show that pretreatment with either ActD or CHX failed
to abolish the CD437-dependent interactions of the
above noted ~85 kD, 55 kD, and 40 kD complexes indicating that these CD437-dependent RNA-protein
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extracts with alkaline phosphatase resulted in loss of
binding of the 85 kD and 55 kD complexes but did not
affect the binding of the ~40 kD and smaller size complexes (figure 5, lane 6). Thus, the data in figure 5 suggest that the CD437-dependent interactions of ~85 kD
and 55 kD proteins, but not the 40 kD and smallersized complexes with the p21WAF1/CIP1 3′-UTR subfragment are dependent on phosphorylation.
A 12 nt sequence of the p21WAF1/CIP1 3′-UTR has a
CD437-responsive cis-element

Figure 3 CD437 targets 3’-UTR sequences of p21WAF1/CIP1 mRNA
independent of their location in the chimeric RBG transcripts.
(A) Two independent sublines derived from stable transfection of
each of the RBG-WAF (1540-1700) plasmid (labelled as A5 and A6)
and WAF (1540-1700)-RBG plasmid (labeled as 1, 2) were grown
either in the absence (-) or presence (+) of 1 μM CD437 for 48 hours.
The cellular RNAs were prepared and northern blot hybridizations
carried out as described in the legend to figure 1. (B) Histogram
showing relative expression of chimeric RBG-WAF transcripts in
control vs CD437-treated sublines in panel A. Northern blots of panel
A were quantitated by soft laser densitometry. Columns represent
mRNA levels relative to the levels of mRNAs present in the untreated
control lanes, which were arbitrarily defined as 1. The error bars
represent the standard error of the mean.

interactions are independent of nascent transcription as
well as protein synthesis. However, the pretreatment of
cytoplasmic protein extracts with Proteinase K resulted
in loss of the binding of the 85 kD and 55 kD complexes while the binding of the ~40 kD and smaller size
complexes was significantly reduced (figure 5, lane 5). In
addition, the pretreatment of cytoplasmic protein

To map CD437-responsive sequences present within the
above 160 nt 3′-UTR RNA subfragment (positions 1540
to 1700, [1]), additional smaller sized fragments were
created by synthesizing oligonucleotides and subsequently cloning the 48 nt long inserts into vector plasmid pBKSII as detailed in Methods. The resultant
pBKS-WAF (1540-1585), pBKS-WAF (1575-1620),
pBKS-WAF (1610-1655) and pBKS-WAF (1645-1690)
plasmids (table 2) were then independently linearized
with XbaI, followed by synthesis of radiolabelled sense
strand RNAs. As observed in the case of the RNA probe
derived from the pBKS-WAF (1540-1700) plasmid
(figure 4B), all of the 45 nt overlapping RNA probes,
with the exception of that derived from the pBKS-WAF
(1610-1655) plasmid, showed specific binding with the
putative ~85 kD and ~55 kD complexes (figure 6A,
lanes 2, 3, 6, 7, 14, and 15). The binding of the proteins
to the RNA probes derived from the pBKS-WAF (15401585), pBKS-WAF (1575-1620) and pBKS-WAF (16451690) plasmids was elevated in the case of cytoplasmic
extracts obtained from HBC cells treated with CD437
for 6 hours (figure 6A, lanes 3, 7, and 15). Thus, the
similarity of the RNA-protein interactions observed in
figure 6A in the case of non-overlapping 45 nt RNA
probe fragments derived from pBKS-WAF (1540-1585)
and pBKS-WAF (1645-1690) plasmids suggests the presence of multiple CD437-responsive sequences within
positions 1540-1700 of p21WAF1/CIP1 mRNA. This observation further supports the data presented in table 1,
where HBC sublines expressing RBG-WAF (581-1498),
RBG-WAF (1498-1645) and RBG-WAF (1645-2004)
transcripts that contain non-overlapping subfragments
of the p21WAF1/CIP1 3′-UTR displayed CD437-dependent
increased expression of chimeric transcripts. Taken
together, the data in figures 4C, 6A and table 1 strongly
support existence of multiple CD437-responsive cissequences that specifically interact with ~55 kD and
~85 kD cytoplasmic protein complexes to elicit CD437dependent elevated expression of p21WAF1/CIP1 in HBC
and leukemia cells.
As observed in figure 6A, the 45 nt overlapping
RNA probes derived from pBKS-WAF (1540-1585)
and pBKS-WAF (1575-1620) plasmids interacted
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Table 2 Plasmid constructs for in vitro transcription
Construct I.D.

Plasmid Name

Positions of the UTR inserts

Gene [ref]

WAF 14.2

pBKS-WAF (518-2110)

3’-UTR +581 to +2110

P21WAF1/CIP1 [1]

WAF 52.1

pBKS-WAF (1540-1710)

3’-UTR +1540 to +1700

P21WAF1/CIP1 [1]

WAF 55.1

pBKS-WAF (1540-1585)

3’-UTR +1540 to +1585

P21WAF1/CIP1 [1]

WAF 56.5

pBKS-WAF (1575-1620)

3’-UTR +1575 to +1620

P21WAF1/CIP1 [1]

WAF 57.8

pBKS-WAF (1610-1655)

3’-UTR +1610 to +1655

P21WAF1/CIP1 [1]

WAF 58.3

pBKS-WAF (1645-1690)

3’-UTR +1645 to +1690

P21WAF1/CIP1 [1]

GADD 12.4

pBKS-GADD (10-55)

5’-UTR +10 to +55

GADD45 [13]

independently with the similar sized HBC cytoplasmic
proteins. To map the CD437-responsive cis element, a
12 nt RNA oligonucleotide from positions 1574-1585
was synthesized and subsequently utilized in RNAprotein interactions in vitro in conjunction with the
cytoplasmic extracts derived from untreated or CD437treated HBC (MCF-7 and MDA-MB-468) as well as
HL-60R leukemia cells as above. As expected, the elevated and specific binding of ~85 kD, 55 kD, 40 kD and
smaller sized complexes with the 12 nt probe was
observed in the cytoplasmic extracts obtained from
CD437-treated leukemia as well as HBC cells (figure 6B,
lanes 3, 7, and 11).

Discussion
Expression of the CDKI p21WAF1/CIP1 during the stress
response is regulated at multiple levels including transcriptional, post-transcriptional and post-translational
[[2] and refs within]. Expression of p21 WAF1/CIP1 in
response to stress stimuli utilizes both the tumor suppressor p53-dependent as well as p53-independent pathways. During cell-cycle progression, p21 WAF1/CIP1
expression fluctuates with peaks at the G 1 and G 2
phases of the cell cycle. Accumulating evidence suggests
that stress-induced expression of p21WAF1/CIP1, in general, protects against stress in order to enhance cell survival by temporarily suppressing cell growth. We have
recently observed that exposure of different cell types,
including HBC, prostate, leukemia and normal mammary epithelial cells to several adamantyl-substituted
retinoids results in rapid induction of p21WAF1/CIP1 followed by apoptosis [8-11]. CD437-dependent induction
of p21WAF1/CIP1 in HBC cells was shown to utilize both
the transcriptional and post-transcriptional mechanisms
independent of cellular p53 [13]. CD437-dependent regulation of p21WAF1/CIP1 in the HBC cells involved, in
part, enhanced message stability utilizing cis sequences
present in the 3′-UTR [13].
In this report, we conducted experiments to further
characterize the CD437-responsive cis sequences present
in the 3′-UTR of p21WAF1/CIP1 mRNA. Using deletion
analyses in combination with in vitro RNA-protein

binding approaches, we found existence of multiple
novel CD437-responsive cis elements and their binding
to specific, perhaps novel, trans-acting cytoplasmic
proteins. We identified a 12 nt RNA sequence
(5′-UGUGGUGGCACA-3′, figure 6) that showed elevated binding to specific cytoplasmic proteins present in
the extracts derived from CD437-treated HBC and leukemia cells. We also found that CD437 treatment of
HBC cells caused elevated expression of chimeric RBGWAF transcripts that contain CD437-responsive
sequences of p21WAF1/CIP1 mRNA. Since the above 12
nt sequence is part of the CD437-responsive p21WAF1/
CIP1
mRNA region, the data in this report strongly
implicate the observed RNA-protein interactions in
CD437-dependent regulation of p21WAF1/CIP1 expression. It should, however, be noted that the p21WAF1/CIP1
3′-UTR RNA sequence of pBKS-WAF (1645-1690) by
not overlapping with above 12 nt sequence yet binding
with protein complexes that were similar to those
observed in the case of 12 nt sequence (see figure 6A,
table 2) highlights the possibility of degeneracy among
the multiple, CD437-responsive sequences present in
the 3′-UTR of p21WAF1/CIP1 mRNA.
Previously, Elav-like RNA-binding proteins were
demonstrated to bind, in vitro, to a 42 nt U-rich
sequence present in the 3′-UTR of p21WAF1/CIP1 mRNA
[5]. HuR, a HuD-related protein of the Elav-like RNAbinding protein family was indeed found to regulate
p21WAF1/CIP1 mRNA stabilization induced by UV light
in human RKO colorectal carcinoma cells [7]. That the
above 12 nt sequence is a novel motif utilized by CD437
to regulate p21WAF1/CIP1 mRNA expression is borne out
by the following observations. First, the 12 nt sequence
identified in this report is located within a 3′-UTR
region that is different from the previously identified
3′-UTR subfragment implicated in binding to the Elavlike mRNA stabilizing proteins [5]. Second, transient
transfection of a plasmid expressing the CMV promoter-driven luciferase reporter gene containing the AUrich region subfragment of p21 WAF1/CIP1 mRNA into
HBC cells failed to elicit CD437-dependent enhanced
luciferase activity [13]. Third, the Elav-like proteins that
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Figure 4 Multiple cell cytoplasmic proteins bind to radiolabelled p21WAF1/CIP1 3’-UTR and GADD45 5’-UTR sense strand riboprobes.
Transcription and labeling of the indicated probes as well as the in vitro binding reactions were as described in the Methods. The probes
utilized and treatment times with CD437 (hr) are indicated above each lane in the respective panels. The cytoplasmic protein extracts were
prepared from untreated (lanes marked 0 hours) or CD437-treated MDA-MB-468 (panels A-C), MCF-7 (panel C) and HL-60R (panel C) cells. Panel
A, the protein extracts in lanes 4-6 and11-13 were pre-incubated with 200-fold excess of the respective unlabeled probe RNAs, while the protein
extracts in lane 7 were pre-incubated with 200-fold excess of the unlabeled 3’-UTR of c-myc RNA followed by incubation with the indicated
labeled probe RNAs. Probe 14.2 RNA is loaded in lane 14. Panel B, the protein extracts in lanes 3 and 6 were pre-incubated with 200-fold excess
of the respective unlabeled probe RNAs, while the protein extracts in lane 7 were pre-incubated with 200-fold excess of the unlabeled 3’-UTR of
c-myc RNA followed by incubation with the indicated labeled probe RNAs. Panel C, lanes 6, 12 represent the labeled probe only. The
approximate migration of molecular weight standards is marked on the left side of respective panel, while the * and ** on the right side of each
panel denote locations of the putative 85 kD and 55 kD complexes, respectively.
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Figure 5 CD437-dependent RNA-protein interactions are
independent of nascent protein synthesis or transcription but
are phosphorylation dependent. The preparation of cytoplasmic
protein extracts from untreated (lanes 0 hour) or CD437-treated
(lanes 2, and 4-6, 6 hours) MDA-MB-468 HBC cells, and transcription
and labeling of the indicated probe as well as in vitro binding
reactions were as described in the methods. The cytoplasmic
extracts were prepared from HBC cells pre-treated with protein
synthesis inhibitor CHX (lanes 1, 2) or transcriptional inhibitor ActD
(lanes 3, 4) followed by treatments with CD437 (time and dose
indicated). In addition, cytoplasmic protein extracts derived from
CD437-treated HBC cells were pretreated with alkaline phosphatase
(lane 6) or proteinase K (lane 5) prior to binding with the indicated
probe. The approximate migration of molecular weight standards is
marked on the left side, whereas the * and ** on the right side of
the panel denote locations of the putative 85 kD and 55 kD
complexes, respectively.

bind the p21WAF1/CIP1 mRNA 3′-UTR consist, in general, of proteins with a molecular weight range of 35-50
kD [5,7]. The CD437-dependent RNA-protein interactions observed in this report consist of multiple
complexes that include 85 kD, 55 kD, 40 kD and smaller-sized complexes that interact with the above 12 nt
sequence. It remains to be determined whether the
CD437-dependent elevated binding of 40 kD and smaller-sized complexes with the 12 nt sequence indeed
involve any Elav-like RNA binding proteins. Fourth, the
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essentially similar nature of RNA-protein interactions
was observed when different RNA probes derived from
p21WAF1/CIP1 and GADD45 mRNAs [pBKS-WAF (15401700) and pBKS-GADD (10-55); figure 4B] as well as
the above 12 nt sequence were separately utilized in
conjunction with the cytoplasmic extracts derived from
CD437-treated HBC cells (see figures 4 and 6). The
45 nt probe derived from the 5′-UTR of GADD45
mRNA [pBKS-GADD (10-55, [12]) has high GC content
and lacks previously characterized AU-rich elements. Its
presence at the 5′ end of the heterologous rabbit bglobin gene caused enhanced expression of chimeric bglobin transcripts in CD437-treated HBC cells [12,14].
Taken together, the CD437-mediated RNA-protein
interactions described in this report suggest the existence of novel pathway(s) targeting the steady-state
levels of cellular mRNAs independent of the involvement of the AU-rich regions of the target mRNAs.
Several labile cellular RNAs are regulated by pathways
that control their degradation. The pathways regulating
steady state levels of cellular RNAs involve interactions
of a number of proteins with cis sequences located in
the UTRs of the target RNAs [15]. The most common
mRNA stability elements involve AU-rich sequences
present in the 3′-UTRs of several short-lived mRNAs
including those encoding for cytokines (interleukins and
interferons), oncogenes (c-myc, c-fos and c-Jun), and
genes regulating cell cycle (for example, p21WAF1/CIP1).
The RNA-protein interactions identified in this study
being independent of the pathways involving AU-rich
sequences is supported by experiments in which the
unlabelled c-myc 3′-UTR (figures 6) or p21 WAF1/CIP1
3′-UTR AU-rich region RNA (clone 7.1, [13], data not
shown) sequences failed to compete for the binding of
the cytoplasmic proteins with radiolabelled probes containing CD437-responsive p21 WAF1/CIP1 sequences.
Taken together, the data suggest that the HBC proteins
interacting with the CD437-responsive cis sequences are
different, perhaps novel, proteins than those binding
with the AU-rich region subfragments of c-myc and
p21WAF1/CIP1 RNAs.
It has been suggested that the factors binding with the
AU-rich RNA elements involved post-translational modification such as phosphorylation [16,17]. Indeed, as
shown in figure 5, pre-treatment of HBC cell cytoplasmic
extracts with alkaline phosphatase abolished the interactions of the proteins with the CD437-responsive
sequences. Although, CD437 did not induce p21WAF1/CIP1
expression in all cell-types, the specific phosphorylationdependent binding of above 85 kD and 55 kD proteins to
a novel RNA cis sequence may constitute an important
pathway regulating the steady-state levels of CD437 target
genes in HBC as well as leukemia cells. Whether factors
binding to AU-rich RNA elements and CD437-responsive
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Figure 6 Multiple CD437-responsive sequence elements exist within the 3’-UTR of p21 WAF1/CIP1. Transcription and labeling of the
indicated probes and binding reactions were as described in the Methods. The probes utilized and treatment times with CD437 (hours, hr) are
indicated in the respective panels. In panel B, the probe sequence of the 12 nt RNA oligonucleotide is shown. The cytoplasmic protein extracts
were prepared from untreated (lanes marked 0) or CD437-treated MDA-MB-468 (panels A, B), MCF-7 (panel B) and HL-60R (panel B) cells. The
respective probes only were loaded in lanes 1, 5, 9, and 13. The protein extracts in lanes 4, 8, 12, and 16 were pre-incubated with 200-fold
excess of the unlabeled RNA derived from pBKS-WAF (1540-1700) plasmid (table 2), followed by incubation with the indicated labeled probe.
The approximate migration of molecular weight standards is marked on the left side of respective panel, while the * and ** on the right side of
each panel denote locations of the putative 85 kD and 55 kD complexes, respectively.

sequences share upstream kinase(s) and/or phosphatase(s)
that may regulate cis-trans interactions remains to be
elucidated.

cytoplasmic proteins with the p21 WAF1/CIP1 mRNA
3′-UTR sequences in a manner independent of the cellular p53 and retinoid receptor status [8,13].

Conclusions
Novel cis sequences located within the 3′-UTR of CDKI
p21WAF1/CIP1 regulate its expression and consequent cell
growth in the presence of the apoptosis-promoting adamantyl-substituted retinoid CD437. CD437 induces specific, phosphorylation-dependent binding of multiple

Methods
Materials

DMEM, Ham’s F-12 medium, and FBS were purchased
from Life Technologies, Inc (Grand Island, NY). The oligonucleotides for PCR amplification (see below) were
purchased from Bio-Synthesis Inc. (Lewisville, TX). The
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RNA oligo was purchased from IDT Inc. (Coralville, IA).
AmpliTaq DNA polymerase and deoxynucleotides were
obtained from Perkin Elmer/Cetus (Norwalk, CT). The
restriction endonucleases and the DNA modification
enzymes were purchased from either Bethesda Research
Laboratories (Bethesda, MD) or New England Biolabs
(Beverley, MA). The T7, T3, and SP-6 RNA polymerase
reagent kits for synthesis of labelled and unlabelled
RNAs were purchased from Promega (Madison, WI).
CD437, CHX and ActD were from Sigma Chemical Co.
(St. Louis, MO).
Cell lines and Cell Culture

The MDA-MB-468 and MCF-7 HBC cells, and HL-60R
human leukemia cells have been described [8,12,13].
HBC cells were grown in Dulbecco’s Modified Eagles
Medium/Ham’s F-12 medium supplemented with 5%
FBS, 20 mM Hepes, and 50 μg/ml gentamicin. HL-60
leukemia cells were grown in RPMI 1640 medium supplemented with 5% heat-inactivated FBS and 25 μg/ml
gentamicin.
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The different subfragments of the p21 WAF1/CIP1
3′-UTR as well as the GADD45 5′-UTR were also subcloned in the vector plasmid pBluescript KSII (Stratagene) for in vitro transcription purposes (table 2). The
plasmids pBKS-WAF (581-2110) and pBKS-GADD
(10-55) have been described [12,13]. The p21WAF1/CIP1
3′-UTR insert of plasmid RBG-WAF (1540-1700) was
subcloned into the pBKSII vector plasmid to obtain the
pBKS-WAF (1540-1700). In addition, overlapping subfragments of the p21 WAF1/CIP1 3′-UTR region from
1540-1700 were generated by synthesizing 49-mer sense
and antisense oligos having 4 nt overhangs for XhoI and
XbaI, respectively. Phosphorylation of each of the oligos
was carried out by using T4 polynucleotide kinase, followed by annealing of the sense oligo with its corresponding antisense partner. The double-stranded,
subfragments were independently ligated into pBSK
vector to obtain plasmids pBKS-WAF (1540-1585),
pBKS-WAF (1575-1620), pBKS-WAF (1610-1655) and
pBKS-WAF (1645-1690). All of the recombinant plasmids were sequenced to confirm the orientation and
sequences of the inserts.

Cloning of Plasmid Constructs

The construction of the plasmid encoding CMV promoter-driven rabbit b-globin (RBG) mRNA has
been described [12]. Plasmids expressing various rabbit
b-globin-p21WAF1/CIP1 (WAF) chimeric transcripts were
generated as follows. First, an ~1.0 kb fragment of the
p21WAF1/CIP1 3′-UTR spanning positions 1006-2004 [1]
present in the plasmid clone 8.7 [13] was isolated by
ApaI and StuI digestions, end-filled by Klenow DNA
polymerase and gel purified. This fragment was ligated
in the sense orientation in the above plasmid encoding
CMV promoter-driven RBG mRNA that was BglIIdigested and blunt-ended to obtain a recombinant plasmid for expression of the RBG-WAF (1006-2004) transcript. Next, the ~1.0 kb insert of plasmid RBG-WAF
(1006-2004) was replaced with the sense orientation of
XhoI-cut 1.4 Kb subfragment of the p21 WAF1/CIP1
3′-UTR (positions 581-2004, [1]) to obtain plasmid for
expression of RBG-WAF (581-2004) transcript. Various
deletion fragments of the p21WAF1/CIP1 3′-UTR (table 1)
were generated by PCR and cloned at the 3′ end of rabbit b-globin gene to obtain plasmids encoding RBGWAF (1498-2004), RBG-WAF (1645-2004), RBG-WAF
(1795-2004), RBG-WAF (1900-2004), RBG-WAF (14981645), RBG-WAF (1540-1700), RBG-WAF (581-1498),
RBG-WAF (581-1195) and RBG-WAF (581-1011) using
previously described methodologies [11,12]. In addition,
the 0.16 kb subfragment of the p21 WAF1/CIP1 3′-UTR
present in plasmid RBG-WAF (1540-1700) was subcloned in the sense orientation at the unique HindIII
site at the 5′ end of the RBG gene to obtain the plasmid
for expression of the WAF (1540-1700)-RBG transcript.

RNA Isolation, Northern Blot Analysis and Stable
Transfections

The plasmids RBG-WAF (581-2004), RBG-WAF (10062004), RBG-WAF (1498-2004), RBG-WAF (1645-2004),
RBG-WAF (1795-2004), RBG-WAF (1900-2004), RBGWAF (1498-1645), RBG-WAF (1540-1700), RBG-WAF
(581-1498), RBG-WAF (581-1195), RBG-WAF (5811011) and WAF (1540-1700)-RBG were independently
transfected into MDA-MB-468 HBC cells, followed by
selection of several hygromycin (400 μg/ml)-resistant
independent sublines from each of the transfection.
Total RNA from each stable subline was isolated and
expression of respective chimeric transcripts analyzed by
the northern blot hybridization using the radiolabelled,
NcoI-BamHI digested, gel-purified exon 2 subfragment
of the RBG gene as described [12,13]. The northern blot
filters were subsequently hybridized with the radiolabelled cDNA fragment corresponding to ribosomal
phosphoprotein 36B4 [18] to ascertain RNA loading.
Analysis of mRNA Decay

Two or more independent hygromycin-resistant MDAMB-468 sublines with low-to-moderate levels of RBG or
RBG-WAF (581-2004) transcripts were selected for analysis of mRNA decay. To study the rate of decay of the
RBG or RBG-WAF (581-2004) transcript, CD437-treated
or untreated sublines were cultured in the presence of
the transcriptional inhibitor ActD (4 μg/ml) for various
times followed by isolation of total RNAs and northern
blot hybridization as described [12]. For measurement of
mRNA decay rates, the data from autoradiograms were
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quantitated by densitometry using the UN-SCAN-IT
software program (Silk Scientific, Inc., Orem, UT). For
each sample, the concentration of RBG transcripts was
normalized to the signal derived from hybridization with
the ribosomal phosphoprotein 36B4 probe. The halflives of the RBG and RBG-WAF (581-2004) mRNAs
were determined essentially as we have described [12].
In Vitro Transcription and Electrophoretic Gel-mobility
Shift Assays

Plasmids pBKS-WAF (581-2110) and pBKS-GADD (1055) were linearized with NotI and HindIII, respectively,
and the T 3 promoter primer was used to synthesize
unlabelled sense strand RNAs as per described methods
[19]. In addition, plasmids pBKS-WAF (1540-1585),
pBKS-WAF (1575-1620), pBKS-WAF (1610-1655) and
pBKS-WAF (1645-1690) were independently linearized
with XbaI, and the unlabelled sense strand RNAs were
synthesized utilizing T7 promoter primer as described
[19]. Radiolabelled probes were also prepared from the
above linearized plasmid templates to the specific activity of ~10 7 cpm/μg of RNA using either [a- 32 P]UTP
(3000 Ci/mmol; 10 mCi/ml; NEN), [a-32 P]CTP (3000
Ci/mmol; 10 mCi/ml; NEN) or a combination of both.
The 12 nt RNA oligonucleotide (5′-UGUGGUGGCACA-3′) was labelled using T4 polynucleotide kinase
and [g 32 P]ATP (3000 Ci/mmol; 10 mCi/ml; NEN) as
described [20]. The radiolabelled RNA probes were subsequently purified using G25 spin columns (BMB) or
Microcon YM-3 spin cartridges with a 3000-dalton
molecular weight cut-off (Millipore, Bedford, MA) and
utilized in the gel-mobility shift assays below.
HBC and leukemia cell cytoplasmic as well as nuclear
protein extracts were prepared according to procedures
described before [20]. HBC cell cytoplasmic extracts
were obtained after treatment of cells with CD437 for 0,
3, 6, 12, and 24 hours. The cytoplasmic protein extracts
from HL-60R leukemia cells were obtained after treatment with CD437 for 0 and 1 hour. In certain cases, the
HBC cells were pretreated with protein synthesis inhibitor CHX (200 μg/ml) or transcriptional inhibitor ActD
(4 μg/ml) for 1-2 hours prior to treatment with CD437.
The protein extracts (20 μg protein per reaction) were
preincubated at room temperature for 10 minutes with
200 ng/μl E. coli tRNA, and 1× binding buffer containing 12 mM HEPES pH7.5, 5 mM MgCl 2 , 1.25 mM
EDTA, 1.25 mM DTT, 155 mM KCl and 10% glycerol
in a total reaction volume of 9 μl. In some cases, proteinase K (Sigma; 5 μg/reaction), calf intestinal alkaline
phosphatase (Boeringer Mannheim Biochemicals; 40
units/reaction), or 2 μl of ~100 ng/μl unlabelled sense
strand RNAs were included in the pre-incubation step.
The specific competitor RNAs consisted either a160 nt
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long RNA derived from plasmid pBKS-WAF (15401700) or an ~1500 nt RNA derived from plasmid
pBKS-WAF (581-2110). The nonspecific competitor
RNA consisted of an ~400 nt 3′-UTR subfragment of cmyc mRNA containing an additional 100 nt poly A
sequences derived from in vitro transcription of HindIII-digested plasmid pMycSD3, essentially as described
[21]. Radiolabelled probe RNA (1 ng/rxn ~10,000 cpm)
was then added to the reaction mix and allowed to incubate at room temperature for additional 30 minutes.
Reactions were then exposed to UV on ice for 5 min
(120 μjoule/min) using UV-crosslinker (Stratagene) to
cross-link the proteins interacting with the RNAs. Five
units of RNAse T1 (BMB) and 2.5 units of RNAse A
(Sigma) were added to each reaction and incubated at
room temperature for 30 minutes. Fifty μg of heparin
(Sigma) was added to each reaction, followed by incubation on ice for 10 minutes. The reactions were boiled
and then analyzed on 12% SDS-polyacrylamide gel
(acrylamide:bisacrylamide, 30:0.8) at 65 V in 1× Tris glycine buffer for a period of 14 to 16 h. Gels were dried
and exposed for autoradiography for appropriate periods
of time.
Abbreviations
CD437: (6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene); HBC: Human
Breast Carcinoma; CDKI: Cyclin-dependent Kinase Inhibitor; ActD:
Actinomycin D; CHX: Cycloheximide; ER: Estrogen Receptor; UTR:
Untranslated region; FBS: Fetal bovine serum; PCR: Polymerase chain
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